RESPONSE TO LETTER TO THE EDITOR
Year : 2022 | Volume
: 28 | Issue : 5 | Page : 399--400
Author's response to “Importance of sample size calculation in a retrospective study of recurrent and non-recurrent acute pancreatitis”
Kun Song, Cuirong Guo, Liudang He, Changluo Li, Ning Ding
Department of Emergency Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South, China
Dr. Ning Ding
Department of Emergency Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, NO.161 Shaoshan South Road, Changsha, Hunan, 410004
|How to cite this article:|
Song K, Guo C, He L, Li C, Ding N. Author's response to “Importance of sample size calculation in a retrospective study of recurrent and non-recurrent acute pancreatitis”.Saudi J Gastroenterol 2022;28:399-400
|How to cite this URL:|
Song K, Guo C, He L, Li C, Ding N. Author's response to “Importance of sample size calculation in a retrospective study of recurrent and non-recurrent acute pancreatitis”. Saudi J Gastroenterol [serial online] 2022 [cited 2022 Dec 6 ];28:399-400
Available from: https://www.saudijgastro.com/text.asp?2022/28/5/399/355682
We appreciate the comments raised by Lopez-Valentin et al., highlighting the importance of sample size estimation in differentiating between the clinical characteristics of recurrent and non-recurrent acute pancreatitis. We are grateful for this opportunity to respond to these comments.
First, in our study, 262 patients were included in the recurrent acute pancreatitis (RAP) group and 1305 in the non-RAP group with a ratio of more than 0.2, which was approprorite for data anlysis between the two groups, with the conclusions thus being reliable.
In the study, RAP group had a significantly lower percentage of cholelithiasis pancreatitis (4.19% vs 17.08%, P < 0.001) and acute liver injury (5.34% vs 11.42%, P < 0.001). It could be partly explained by the fact that the probability of recurrence after an episode of cholelithiasis-related acute pancreatitis (AP) was related to whether and how long after an attack an appropriate procedure such as endoscopic retrograde cholangiopancreatography (ERCP) or cholecystectomy was done, and the risk of recurrence and acute liver injury was eliminated if surgery was done, as stated in our manuscript.
Second, in our study, three factors associated with RAP including male, diabetes and hypertriglyceridemia (HTG) were identified by multivariate logistic regression analysis. Males with diabetes and HTG were more likely to develop RAP. As highlighted by Lopez-Valentin et al., there remains a possibility that some factors may interacted with each other, given that the proportions of males and diabetes were both significantly higher in the RAP group. In our retrospective analysis, we did not aim to make some prognostic biomarkers or predictive models for RAP occurrence. We only focused on the differences between RAP and the non-RAP in order to provide some potential clinical suggestions. In addition, differences in AP etiologies may result from different lifestyles and socioeconomic status in different regions., In recent years, the incidence of AP due to HTG has been increasing yearly in China, which might partly explain that HTG was a risk factor for RAP.
In future, studies with subgroup analyses with more clinical and laboratory variables should be done in order to find effective treatments like drugs and interventions for RAP patients with different etiologies.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
|1||Lopez-Valentin J, Aguilar-Padilla A, Tirado-Hurtado I. The importance of sample size calculation in a retrospective study of recurrent and non-recurrent acute pancreatitis. Saudi J Gastroenterol 2022;28:393-4.|
|2||Song K, Guo C, He L, Li C, Ding N. Different clinical characteristics between recurrent and non-recurrent acute pancreatitis: A retrospective cohort study from a tertiary hospital. Saudi J Gastroenterol 2022;28:282-7.|
|3||Yu B, Li J, Li N, Zhu Y, Chen Y, He W, et al. Progression to recurrent acute pancreatitis after a first attack of acute pancreatitis in adults. Pancreatology 2020;20:1340-6.|
|4||Yang A, Vadhavkar S, Singh G, Omary M. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med 2008;168:649-56.|
|5||Gao YJ, Li YQ, Wang Q, Li SL, Li GQ, Ma J, et al. Analysis of the clinical features of recurrent acute pancreatitis in China. J Gastroenterol 2006;41:681-5.|
|6||Zhang R, Deng L, Jin T, Zhu P, Shi N, Jiang K, et al. Hypertriglyceridaemia-associated acute pancreatitis: Diagnosis and impact on severity. HPB (Oxford) 2019;21:1240-9.|